503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-7.92%
Revenue decline while CRWV shows 23.55% growth. Joel Greenblatt would examine competitive position erosion.
-9.42%
Cost reduction while CRWV shows 19.16% growth. Joel Greenblatt would examine competitive advantage.
-7.56%
Gross profit decline while CRWV shows 25.15% growth. Joel Greenblatt would examine competitive position.
0.38%
Margin expansion below 50% of CRWV's 1.30%. Michael Burry would check for structural issues.
1.63%
R&D change of 1.63% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
52.04%
G&A growth while CRWV reduces overhead. John Neff would investigate operational differences.
-12.16%
Marketing expense reduction while CRWV shows 248.84% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
0.87%
Operating expenses growth less than half of CRWV's 17.97%. David Dodd would verify sustainability.
-2.34%
Total costs reduction while CRWV shows 18.28% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-23.38%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
-16.51%
EBITDA decline while CRWV shows 33.05% growth. Joel Greenblatt would examine position.
-10.40%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
-16.51%
Operating income decline while CRWV shows 169.93% growth. Joel Greenblatt would examine position.
-9.34%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
-11.04%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-16.00%
Pre-tax income decline while CRWV shows 9.63% growth. Joel Greenblatt would examine position.
-8.78%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
-9.84%
Tax expense reduction while CRWV shows 3.78% growth. Joel Greenblatt would examine advantage.
-18.51%
Net income decline while CRWV shows 7.67% growth. Joel Greenblatt would examine position.
-11.50%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
-17.14%
EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-14.71%
Diluted EPS decline while CRWV shows 23.08% growth. Joel Greenblatt would examine position.
-2.43%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-2.10%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.